<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948425</url>
  </required_header>
  <id_info>
    <org_study_id>AVC AIGUS</org_study_id>
    <secondary_id>2017/12AVR/209</secondary_id>
    <nct_id>NCT03948425</nct_id>
  </id_info>
  <brief_title>Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke</brief_title>
  <acronym>AVC_AIGUS</acronym>
  <official_title>Cerebral Dynamic Perfusion Study With Spectral CT in Patients Suspected of Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Generate a dynamic mapping of the distribution of iodine within the cerebral parenchyma
           in the patient suspected of acute ischemic disorder with the CT spectral scanner.

        -  Correlate the anomalies of iodine mapping to the other parameters acquired during the
           classic dynamic infusion phase to define the ischemic area (MTT higher and rCBV normal)
           versus infarcted zone (MTT higher and rCBV decreased)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral Blood Volume (CBV)</measure>
    <time_frame>from start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>CBV is measured in units of milliliters of blood per 100 g of brain and is defined as the volume of flowing blood for a given volume of brain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Transit Time (MTT)</measure>
    <time_frame>rom start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>MTT is measured in seconds and defined as the average amount of time it takes blood to transit through the given volume of brain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral Blood Flow (CBF)</measure>
    <time_frame>rom start of the study procedure (CT scan) through end of study procedure (from 15 minutes to 30 minutes)</time_frame>
    <description>CBF is measured in units of milliliters of blood per 100 g of brain tissue per minute and is defined as the volume of flowing blood moving through a given volume of brain in a specific amount of time.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical suspicion of hyperacute stroke (6 hours after onset of symptoms):Intervention 'spectral CT'</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>spectral CT</intervention_name>
    <description>Head spectral CT</description>
    <arm_group_label>Stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical suspicion of hyperacute stroke (6 hours after onset of symptoms)

          -  Age between 50 and 95 years

          -  Weight: between 65 and 95 kg

        Exclusion Criteria:

          -  Documented or suspected allergy to IV iodinated contrast media

          -  Renal impairment with creatinine clearance &lt;60 ml / min

          -  Hemorrhagic lesions or vascular abnormalities demonstrated on CT before contrast
             injection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Coche, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Coche, MD-PhD</last_name>
    <phone>+3227642918</phone>
    <email>emmanuel.coche@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques universitaires saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Coche, MD-PhD</last_name>
      <phone>+32 2 7642918</phone>
      <email>emmanuel.coche@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>May 9, 2019</last_update_submitted>
  <last_update_submitted_qc>May 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

